---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-004599"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2025-04-08T23:59:59+00:00"
generated_at: "2026-05-23T19:08:58.992892+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Xilio receives Nasdaq bid-price deficiency letter for shares below $1.00

## Summary
- Notice dated April 4, 2025; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Oct 1, 2025) to regain compliance.
- To cure, bid price must close at or above $1.00 for at least 10 consecutive business days.
- If not cured, Xilio may transfer to Nasdaq Capital Market for an additional 180-day period.
- No immediate effect on listing; company evaluating options to regain compliance.

## SEC filing metadata
- accession: 0001558370-25-004599
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2025-04-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000155837025004599/0001558370-25-004599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000155837025004599/xlo-20250404x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-004599
- JSON: https://secwatch.observer/filing/0001558370-25-004599.json
- Plain text: https://secwatch.observer/filing/0001558370-25-004599.txt

## Key facts
- Listing & Compliance Notices
  Xilio Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: April 4, 2025, Xilio Therapeutics, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). ​ The Notice has no immediate effect on the listing of the Company’s common
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840233/000155837025004599/0001558370-25-004599-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.